View on market: Stay Cautious, be with quality business:

Asian markets opened on a positive note on Friday morning, the Japanese shares are higher today as the Nikkei 225 gains 1.05%, as of 6:29 am, IST. U.S. stocks were upbeat on data indicating moderation in the labour market, paving the way for less hawkish Federal Reserve stance. The S&P 500 rose 0.7%, while the tech heavy the Nasdaq 100 was up 1%. The yield of 10-year Treasuries advanced five basis points to 3.44%. Oil was up 0.8% after paring significant gains from a volatile session caused due to shutdown of a crucial pipeline between the U.S. and Canada. Gold futures rose 0.2%, whereas Bitcoin rose 0.7% to trade around $17,000-level. The Indian benchmark indices opened on a marginally positive note and stayed flat through the session before closing higher on the back of a last hour surge. Overseas Investors in Indian equities remained net sellers for the fourth straight day on Thursday. Foreign portfolio investors offloaded equities worth Rs 1,131.67 crore, according to data from the National Stock Exchange. Domestic institutional investors turned net buyers and bought equities worth Rs 772.29 crore. Rupee maintained its upward trajectory against the U.S. dollar for the second day after paring initial losses. At 6:29 a.m., the Singapore-traded SGX Nifty — an early barometer of India’s benchmark Nifty 50 — rose 0.22% to 18,769.5.

Economic Calendar:

  • USD : CPI (MoM) (Nov) on 13th December, 2022
  • USD : PPI (MoM) (Nov) on 9th December, 2022
  • INR : FX Reserves, USD on 9th December, 2022
  • INR : CPI (YoY) (Nov) on 12th December, 2022

Brokerage Radar:

CITI ON HUL: Buy, TP Rs 3050; Foray Into Health & Wellbeing: Targeting Growth In New-Age Categories; As per mgmt.,vitamins, minerals & supplements category can potentially become Rs300bn in medium term; Co intends to focus on some high-growth benefit spaces within VMS

MS ON OMCs: India fuel basket is priced at $93/bbl Brent, & if oil remains near $80s, Indian energy equities should see upside risk to expectations, with crude OSPs falling & above-midcycle fuel cracks benefiting refiners BPCL/IOCL; Potential removal of export tax could be +ve

JPM ON RIL: OW, TP Rs 3065; 2023- Earnings should improve; stock returns to be driven mainly by Jio Financial Services; markets not ascribing material value yet; Believe CY23 will likely be mostly about Jio Financial as Consumer biz (Jio, Retail) IPOs are still some time away; While New Energy remains most interesting part of co’s longer-term earnings & val story, do not expect any immediate monetization; Cut FY23 EPS by 8%, expect FY24 to be better on stable refining, better Petrochem, higher E&P & stronger Retail

International Markets:

U.S & Europe

Particulars 08th December Chg. Chg.(%)
Nasdaq 11082.00 123.45 1.13
Dow 33781.48 183.56 0.55
FTSE 7472.17 -17.02 -0.23
CAC 6647.31 -13.28 -0.20
DAX 14264.56 3.37 0.02
Dow Fut.* 33801.30 19.80 0.06

Asian markets

Particulars 09th December Chg. Chg.(%)
SGX Nifty 18793.50 66.00 0.35
Nikkei 27946.21 371.78 1.35
Straits Times 3239.43 3.35 0.10
Hang Seng 19515.01 64.78 0.33
Shanghai 3186.50 -10.85 -0.34

ADR Watch:

Particulars 08th December  Chg.       Chg.(%)
Dr. Reddy 53.71 0.46 0.86
HDFC Bank 68.03 0.46 0.68
ICICI Bank 22.85 0.16 0.71
Infosys 19.58 0.19 0.98
Tata Motor 24.96 0.05 0.20
Wipro 4.93 0.03 0.61

Commodities & Currency

Particulars Current Price Chg.(%)
USD/INR 82.42 -0.06
Brent 76.73 0.27
Gold 1805.40 0.22
Silver 23.407 0.69

FIIs & DIIs:

Particulars 08th December 07th December
FIIs                           -1131.67 -1241.87
DIIs 772.29 388.85

News Update:

One 97 Communications: The board will meet on Dec. 13 to consider a proposed share buyback programme.

Adani Enterprises: Acquired 100% stake of Alluvial Mineral Resources from Adani Infra (India).

Sun Pharmaceuticals: The USFDA has listed the company’s Halol manufacturing facility under ‘Import Alert’. The company has not revised the revenue guidance for the current fiscal.

Ahluwalia Contracts (India): Clarified inter alia that the Rs 55.39-crore contract at Plaksha University, Punjab is a domestic project and will be executed within 15 months.

Hindustan Unilever: Will acquire 100% stake of Zywie Ventures in cash deal, to be completed in two tranches. The company will also acquire 19.8% stake in Nutritionalab for Rs 70 crore.

Lupin: Appointed Spiro Gavaris as the president of its U.S. Generics business.

Max Financial Services: Completed the acquisition of balance 5.17% stake held by Mitsui Sumitomo Insurance Co., Japan in subsidiary Max Life Insurance Co., taking its overall shareholding to 87%.

HCL Tech: Management has indicated that growth for FY23 will come at the lower end of the range that it had indicated post its 2QFY23 results due to higher-than-expected furloughs, according to Nirmal Bang.

Source: Moneycontrol, Bloomberg Quint, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited,
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting, or emailing with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website:
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL